Long COVID syndrome-associated brain fog.
COVID-19
SARS-CoV-2
brain
coronavirus
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
13
10
2021
received:
14
07
2021
accepted:
18
10
2021
pubmed:
22
10
2021
medline:
7
6
2022
entrez:
21
10
2021
Statut:
ppublish
Résumé
We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19) who have survived the illness. We also scrutinized the potential risk factors associated with the development of brain fog. Adult patients (18-55 years of age), who were referred to the healthcare facilities anywhere in Fars province from February 19, 2020 to November 20, 2020 were included. All patients had a confirmed COVID-19 diagnosis. In a phone call, at least 3 months after their discharge from the hospital, we obtained their current information. A questionnaire was specifically designed for data collection. In total, 2696 patients had the inclusion criteria; 1680 (62.3%) people reported long COVID syndrome (LCS). LCS-associated brain fog was reported by 194 (7.2%) patients. Female sex (odds ratio [OR]: 1.4), respiratory problems at the onset (OR: 1.9), and intensive care unit (ICU) admission (OR: 1.7) were significantly associated with reporting chronic post-COVID "brain fog" by the patients. In this large population-based study, we report that chronic post-COVID "brain fog" has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness (ICU admission).
Identifiants
pubmed: 34672377
doi: 10.1002/jmv.27404
pmc: PMC8662118
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
979-984Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Lung. 2021 Apr;199(2):113-119
pubmed: 33569660
J Neurol Sci. 2020 Jun 15;413:116832
pubmed: 32299017
J Med Virol. 2022 Mar;94(3):979-984
pubmed: 34672377
J Neurol Sci. 2021 Jul 15;426:117486
pubmed: 34000678
Biofactors. 2021 Mar;47(2):232-241
pubmed: 33847020
J Psychiatr Res. 2020 Oct;129:98-102
pubmed: 32912598
Thorax. 2021 Apr;76(4):399-401
pubmed: 33273026
J Biol Regul Homeost Agents. 2021 Jun 08;35(3):833-838
pubmed: 34100279
Clin Microbiol Infect. 2021 Oct;27(10):1507-1513
pubmed: 34111579
Healthcare (Basel). 2021 May 13;9(5):
pubmed: 34068009
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
Pain Rep. 2021 Feb 16;6(1):e887
pubmed: 33615088
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):145-146
pubmed: 33341598
Med Sci Monit. 2021 Jan 25;27:e930886
pubmed: 33487628
Eur Neuropsychopharmacol. 2021 May;46:39-48
pubmed: 33823427
Int J Obes (Lond). 2021 Jun;45(6):1163-1169
pubmed: 33727631
J Neurol. 2022 Jan;269(1):44-46
pubmed: 34143277
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
BMJ Open. 2021 Mar 10;11(3):e047632
pubmed: 33692189
J Neurovirol. 2021 Feb;27(1):191-195
pubmed: 33528824